These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 3135973)

  • 21. [Long-term therapy with nitrates. How can continuous effectiveness be achieved?].
    Rudolph W; Dirschinger J; Reiniger G; Beyerle A
    Fortschr Med; 1989 Jun; 107(19):41-2, 45-7. PubMed ID: 2668139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance to the increase in coronary blood flow induced by KRN2391.
    Kaneta S; Jinno Y; Harada K; Fukushima H; Ogawa N
    Arch Int Pharmacodyn Ther; 1992; 318():21-35. PubMed ID: 1463369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrate tolerance.
    Parker JO
    Am J Cardiol; 1987 Nov; 60(15):44H-48H. PubMed ID: 3120566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigations into the development of tolerance to organic nitrates in conscious dogs.
    Sponer G; Strein K; Dietmann K; Abshagen U
    Arzneimittelforschung; 1984; 34(11):1510-3. PubMed ID: 6441580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamics and exercise tolerance during application of transdermal systems with phasic nitroglycerin (NTG) release in comparison to 20 mg isosorbide mononitrate.
    Jansen W; Hinsche A; Rappert B; Geppert R; Tauchert M
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):505-6. PubMed ID: 1490809
    [No Abstract]   [Full Text] [Related]  

  • 27. Nitrate tolerance--problems both new and old.
    Parker JO
    Can J Cardiol; 1996 May; 12 Suppl C():5C-8C. PubMed ID: 8634921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the use of long acting nitrates beneficial in the patient with angina pectoris? (The negative side).
    Goldstein RE
    Cardiovasc Clin; 1977; 8(1):149-58. PubMed ID: 403005
    [No Abstract]   [Full Text] [Related]  

  • 29. Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate.
    Thadani U; Manyari D; Parker JO; Fung HL
    Circulation; 1980 Mar; 61(3):526-35. PubMed ID: 6766360
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanisms of action of nitrates.
    Torfgård KE; Ahlner J
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):701-17. PubMed ID: 7873467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transdermal forms of nitrates].
    Penkov N; Sirakova V
    Vutr Boles; 1989; 28(5):12-6. PubMed ID: 2515658
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate.
    Gori T; Daiber A
    Am J Cardiovasc Drugs; 2009; 9(1):7-15. PubMed ID: 19178128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of nitroglycerin and long-acting nitrates.
    Abrams J
    Am J Cardiol; 1985 Jul; 56(2):12A-18A. PubMed ID: 3925750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sustained release formulation of isosorbide-5-mononitrate with a rapid onset of action.
    Arthur RM; Mehmel H
    Int J Clin Pract; 1999; 53(3):205-12. PubMed ID: 10665134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent developments in the use of nitrates for treatment of angina pectoris.
    Ankier SI; Warrington SJ; Sneddon JM
    J Int Med Res; 1988; 16(4):249-56. PubMed ID: 3139481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some pharmacological properties of organic nitrates.
    Osnes JB
    Scand J Clin Lab Invest Suppl; 1984; 173():19-25. PubMed ID: 6098958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
    Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
    Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitro compounds (isosorbide dinitrate, 5-isosorbide mononitrate and glyceryl trinitrate) on the femoral vein and femoral artery.
    Toyoda J; Hisayama T; Takayanagi I
    Gen Pharmacol; 1986; 17(1):89-91. PubMed ID: 3081404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selected issues from an overview on nicorandil: tolerance, duration of action, and long-term efficacy.
    Wagner G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S86-92. PubMed ID: 1282183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.